20/06/2024 Healthcare
Ceftriaxone 250 mg Injection, marketed as Triazo 250, is a third-generation cephalosporin antibiotic used to treat bacterial infections. It works by disrupting bacterial cell wall synthesis, leading to bacterial death. Triazo 250 is administered intravenously or intramuscularly, providing broad-spectrum coverage against Gram-positive and Gram-negative organisms. It is prescribed for various infections, including respiratory tract infections, urinary tract infections, and septicemia, ensuring effective treatment under medical supervision.Available in PCD Franchise for injectable range and third party manufacturing.
Ceftriaxone 500 mg Injection, marketed as Triazo 500, is a potent third-generation cephalosporin antibiotic effective against severe bacterial infecti...
Ceftriaxone 250 mg Injection, marketed as Triazo 250, is a third-generation cephalosporin antibiotic used to treat bacterial infections. It works by d...
Ceftriaxone 1000 mg Sulbactam 500 mg, marketed as Triazo-S 1.5 mg, combines a third-generation cephalosporin antibiotic with a beta-lactamase inhibito...
Ceftriaxone Sulbactam for Injection, marketed as Doracef-S Injection, combines ceftriaxone, a potent antibiotic, with sulbactam, a β-lactamase inhibit...
More Details